
Tissue banks facilitate the collection and banking of freshly-frozen tissue specimens. These tissues play a vital role in research into diseases and disorders, and general healthcare.
Highlights
The global Tissue Banking market was valued at US$ 3678.3 million in 2022 and is anticipated to reach US$ 6445.6 million by 2029, witnessing a CAGR of 9.8% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Tissue banking market is mainly driven by increasing awareness for blood and tissue donation. On an average 22 people die each day while waiting for organ transplantation and every 10 minutes someone is added to the waiting list for organ transplantation. Moreover, increasing chronic diseases, the government initiative, and improvement of health care facilities influence the growth of tissue banking market. However, bioethical issues and cost of tissue preservation are responsible for restraining the growth of tissue banking market. Nevertheless, untapped market and new advanced techniques for tissue banking are likely to open new opportunities for the tissue banking market in the forecast period.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Tissue Banking, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tissue Banking.
The Tissue Banking market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Tissue Banking market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tissue Banking companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Thermo Fisher
Brooks Automation
Worthington Industries
Custom Biogenic Systems
Panasonic Healthcare
BioLife Solutions
Merck & Co., Inc. (Sigma-Aldrich Corporation)
Hamilton Bonaduz
Beckman Coulter
Segment by Type
Cardiovascular Tissue
Lung Tissue
Kidney Tissue
Pancreas Tissue
Liver Tissue
Eye Tissue
Others
Segment by Application
Hospitals
Tissue Banks
Research and Academics Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tissue Banking companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Âé¶¹Ô´´ Analysis by Type
1.2.1 Global Tissue Banking Âé¶¹Ô´´ Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Cardiovascular Tissue
1.2.3 Lung Tissue
1.2.4 Kidney Tissue
1.2.5 Pancreas Tissue
1.2.6 Liver Tissue
1.2.7 Eye Tissue
1.2.8 Others
1.3 Âé¶¹Ô´´ by Application
1.3.1 Global Tissue Banking Âé¶¹Ô´´ Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Tissue Banks
1.3.4 Research and Academics Institutes
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tissue Banking Âé¶¹Ô´´ Perspective (2018-2029)
2.2 Tissue Banking Growth Trends by Region
2.2.1 Global Tissue Banking Âé¶¹Ô´´ Size by Region: 2018 VS 2022 VS 2029
2.2.2 Tissue Banking Historic Âé¶¹Ô´´ Size by Region (2018-2023)
2.2.3 Tissue Banking Forecasted Âé¶¹Ô´´ Size by Region (2024-2029)
2.3 Tissue Banking Âé¶¹Ô´´ Dynamics
2.3.1 Tissue Banking Industry Trends
2.3.2 Tissue Banking Âé¶¹Ô´´ Drivers
2.3.3 Tissue Banking Âé¶¹Ô´´ Challenges
2.3.4 Tissue Banking Âé¶¹Ô´´ Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tissue Banking Players by Revenue
3.1.1 Global Top Tissue Banking Players by Revenue (2018-2023)
3.1.2 Global Tissue Banking Revenue Âé¶¹Ô´´ Share by Players (2018-2023)
3.2 Global Tissue Banking Âé¶¹Ô´´ Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Tissue Banking Revenue
3.4 Global Tissue Banking Âé¶¹Ô´´ Concentration Ratio
3.4.1 Global Tissue Banking Âé¶¹Ô´´ Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tissue Banking Revenue in 2022
3.5 Tissue Banking Key Players Head office and Area Served
3.6 Key Players Tissue Banking Product Solution and Service
3.7 Date of Enter into Tissue Banking Âé¶¹Ô´´
3.8 Mergers & Acquisitions, Expansion Plans
4 Tissue Banking Breakdown Data by Type
4.1 Global Tissue Banking Historic Âé¶¹Ô´´ Size by Type (2018-2023)
4.2 Global Tissue Banking Forecasted Âé¶¹Ô´´ Size by Type (2024-2029)
5 Tissue Banking Breakdown Data by Application
5.1 Global Tissue Banking Historic Âé¶¹Ô´´ Size by Application (2018-2023)
5.2 Global Tissue Banking Forecasted Âé¶¹Ô´´ Size by Application (2024-2029)
6 North America
6.1 North America Tissue Banking Âé¶¹Ô´´ Size (2018-2029)
6.2 North America Tissue Banking Âé¶¹Ô´´ Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Tissue Banking Âé¶¹Ô´´ Size by Country (2018-2023)
6.4 North America Tissue Banking Âé¶¹Ô´´ Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Tissue Banking Âé¶¹Ô´´ Size (2018-2029)
7.2 Europe Tissue Banking Âé¶¹Ô´´ Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Tissue Banking Âé¶¹Ô´´ Size by Country (2018-2023)
7.4 Europe Tissue Banking Âé¶¹Ô´´ Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tissue Banking Âé¶¹Ô´´ Size (2018-2029)
8.2 Asia-Pacific Tissue Banking Âé¶¹Ô´´ Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Tissue Banking Âé¶¹Ô´´ Size by Region (2018-2023)
8.4 Asia-Pacific Tissue Banking Âé¶¹Ô´´ Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Tissue Banking Âé¶¹Ô´´ Size (2018-2029)
9.2 Latin America Tissue Banking Âé¶¹Ô´´ Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Tissue Banking Âé¶¹Ô´´ Size by Country (2018-2023)
9.4 Latin America Tissue Banking Âé¶¹Ô´´ Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tissue Banking Âé¶¹Ô´´ Size (2018-2029)
10.2 Middle East & Africa Tissue Banking Âé¶¹Ô´´ Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Tissue Banking Âé¶¹Ô´´ Size by Country (2018-2023)
10.4 Middle East & Africa Tissue Banking Âé¶¹Ô´´ Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher
11.1.1 Thermo Fisher Company Detail
11.1.2 Thermo Fisher Business Overview
11.1.3 Thermo Fisher Tissue Banking Introduction
11.1.4 Thermo Fisher Revenue in Tissue Banking Business (2018-2023)
11.1.5 Thermo Fisher Recent Development
11.2 Brooks Automation
11.2.1 Brooks Automation Company Detail
11.2.2 Brooks Automation Business Overview
11.2.3 Brooks Automation Tissue Banking Introduction
11.2.4 Brooks Automation Revenue in Tissue Banking Business (2018-2023)
11.2.5 Brooks Automation Recent Development
11.3 Worthington Industries
11.3.1 Worthington Industries Company Detail
11.3.2 Worthington Industries Business Overview
11.3.3 Worthington Industries Tissue Banking Introduction
11.3.4 Worthington Industries Revenue in Tissue Banking Business (2018-2023)
11.3.5 Worthington Industries Recent Development
11.4 Custom Biogenic Systems
11.4.1 Custom Biogenic Systems Company Detail
11.4.2 Custom Biogenic Systems Business Overview
11.4.3 Custom Biogenic Systems Tissue Banking Introduction
11.4.4 Custom Biogenic Systems Revenue in Tissue Banking Business (2018-2023)
11.4.5 Custom Biogenic Systems Recent Development
11.5 Panasonic Healthcare
11.5.1 Panasonic Healthcare Company Detail
11.5.2 Panasonic Healthcare Business Overview
11.5.3 Panasonic Healthcare Tissue Banking Introduction
11.5.4 Panasonic Healthcare Revenue in Tissue Banking Business (2018-2023)
11.5.5 Panasonic Healthcare Recent Development
11.6 BioLife Solutions
11.6.1 BioLife Solutions Company Detail
11.6.2 BioLife Solutions Business Overview
11.6.3 BioLife Solutions Tissue Banking Introduction
11.6.4 BioLife Solutions Revenue in Tissue Banking Business (2018-2023)
11.6.5 BioLife Solutions Recent Development
11.7 Merck & Co., Inc. (Sigma-Aldrich Corporation)
11.7.1 Merck & Co., Inc. (Sigma-Aldrich Corporation) Company Detail
11.7.2 Merck & Co., Inc. (Sigma-Aldrich Corporation) Business Overview
11.7.3 Merck & Co., Inc. (Sigma-Aldrich Corporation) Tissue Banking Introduction
11.7.4 Merck & Co., Inc. (Sigma-Aldrich Corporation) Revenue in Tissue Banking Business (2018-2023)
11.7.5 Merck & Co., Inc. (Sigma-Aldrich Corporation) Recent Development
11.8 Hamilton Bonaduz
11.8.1 Hamilton Bonaduz Company Detail
11.8.2 Hamilton Bonaduz Business Overview
11.8.3 Hamilton Bonaduz Tissue Banking Introduction
11.8.4 Hamilton Bonaduz Revenue in Tissue Banking Business (2018-2023)
11.8.5 Hamilton Bonaduz Recent Development
11.9 Beckman Coulter
11.9.1 Beckman Coulter Company Detail
11.9.2 Beckman Coulter Business Overview
11.9.3 Beckman Coulter Tissue Banking Introduction
11.9.4 Beckman Coulter Revenue in Tissue Banking Business (2018-2023)
11.9.5 Beckman Coulter Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Thermo Fisher
Brooks Automation
Worthington Industries
Custom Biogenic Systems
Panasonic Healthcare
BioLife Solutions
Merck & Co., Inc. (Sigma-Aldrich Corporation)
Hamilton Bonaduz
Beckman Coulter
Ìý
Ìý
*If Applicable.
